Description

Autotransfusion is a medical procedure in which the lost blood of a patient is collected and returned to the same patient. It should be considered in every trauma patient while in the emergency department. Autotransfusion can also be used in patients undergoing surgery or any patient with anticipated blood loss without contraindications. The global autotransfusion device market is poised to grow by US$ 155.5 million during 2022-2028, progressing at a CAGR of 2.1% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for autotransfusion device. The global autotransfusion device market is segmented on the basis of product, application, end user, and region. By product, the global autotransfusion device market has been segmented into devices, accessories. Based upon application, the global autotransfusion device market is categorized into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, others. On the basis of end user, the global autotransfusion device market has been segmented into ambulatory surgery centers (ASCs), hospitals, specialty clinics. Geographically, the global autotransfusion device market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global autotransfusion device market is highly competitive. Key companies profiled in the report include Advancis Surgical (Brightwake Limited), Atrium Medical Corporation (MAQUET Cardiovascular LLC), Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic PLC, Stryker Corporation, Terumo Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the autotransfusion device market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: devices, accessories
Application: cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, others
End user: ambulatory surgery centers (ASCs), hospitals, specialty clinics
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global autotransfusion device market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Autotransfusion device market overview
Part 3. Market breakdown by product
– Devices
– Accessories
Part 4. Market breakdown by application
– Cardiac surgeries
– Orthopedic surgeries
– Organ transplantation
– Trauma procedures
– Others
Part 5. Market breakdown by end user
– Ambulatory surgery centers (ASCs)
– Hospitals
– Specialty clinics
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Advancis Surgical (Brightwake Limited)
– Atrium Medical Corporation (MAQUET Cardiovascular LLC)
– Fresenius SE & Co. KGaA
– Haemonetics Corporation
– LivaNova, PLC
– Medtronic PLC
– Stryker Corporation
– Terumo Corporation
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Statistics

Release Date

May 2022

Region

Global

Pages

19

REQUEST SAMPLE

Global Autotransfusion Device Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Autotransfusion Device Market 2022

Please fill out our form and we will get back to you.

login